The 3rd leg of fatty acid metabolism

The peroxisome proliferator-activated receptors (PPAR) have been extremely successful as drug targets, with numerous marketed drugs targeting the alpha and gamma PPARs. Now, work by researchers at GlaxoSmithKline plc (GSK, London, U.K.) suggests that the function of a third

Read the full 398 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE